Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hua Medicine
Pharma
BeiGene, Bayer-Hua, Novavax-Fujifilm and more—Fierce Pharma Asia
BeiGene's Brukinsa trounces Imbruvica in phase 3. China's Hua and Bayer wins an industry-first diabetes nod. Novavax caps Fujifilm COVID vaccine deal.
Angus Liu
Oct 14, 2022 9:05am
Bayer, Hua snag first-in-class diabetes nod for Roche castoff
Oct 10, 2022 10:40am
GSK, Akebia and Takeda—FiercePharmaAsia
Jul 2, 2020 10:15am
